Surprising GLP-1 side effects Commenting on which newly identified symptoms were the most surprising, Neil Sehgal, ME, MS, the studys first author and a doctoral student advised by Guntuku and Lyle Ungar, PhD, told Medical News Today :\ There were a few interesting findings
Sodium, potassium, and magnesium are the big three to watch
With clinically meaningful weight loss and cardiovascular outcomes in patients with type 2 diabetes, GLP-1RAs were further assessed in patients with overweight or obesity without type 2 diabetes in the 2021 STEP-1 trial and 2022 SURMOUNT-1 trial
Retatrutide is being studied primarily for adults dealing with obesity or overweight conditions with related health complications
That means it turns on the glucagon receptor in your body
Los pacientes con diabetes tipo 2 tienen dificultades para producir una cantidad suficiente de insulina o para utilizar la insulina eficazmente, lo que a menudo conduce a niveles elevados de glucosa en sangre
